Effetti Precoci e Tardivi Dell'eritropoietina Sul Metabolismo Glicidico in Pazienti Emodializzati

Scigalla P. , Wieczorek L. , Bicker U. Treatment of renai anemia with recombinant human erythropoietin: European experience. In: Garnick M.B. ed. Erythropoietin in Clinical applications. An international perspective. New York: Marcel Dekker 1990; 141–82.

Sobota J.T. Erythropoietin treatment of end-stage renal disease: North American and Japanese experience. In: Garnick M.B. , ed. Erythropoietin in Clinical applications. An international perspective. New York: Marcel Dekker 1990; 183–219.

Winearls C.G. , Oliver D.O. , Pippard M.J. , Reid C. , Downing M.R. , Cotes P.M. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet 1986; 2: 1175–8.

Eschbach J.W. , Egrie J.C. , Downing M.R. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med 1987; 316: 73–8.

Fischer Ch , Scigalla P. , Park W. Influence of rHuEPO therapy on the protein metabolism of hemodialysis patients with terminal renal insufficiency. Contrib Nephrol 1989; 76: 250–6.

Riedel E. , Hampl H. , Scigalla P. , Nundel M. , Kessel M. Correction of amino acid metabolism by recombinant human erythropoietin therapy in hemodialysis patients. Kidney Int 1989; 36(Suppl 27): S216–21.

Acone D. , Di Maio F.S. , Conte D. , Giordano C. Effetto della terapia con rHuEPO sul metabolismo lipidico nel paziente in emodialisi. Giorn It Nefrol 1991; 8(Suppl 1): 469 (abstr.)

Mat O. , Stolear J.C. , Georges B. Blood lipid profile in hemodialysis patients treated with human erythropoietin. Nephron 1992; 60: 236–7.

Viron B. , Donsimoni R. , Michel C. , Al Khayat R. , Mignon F. Effect of recombinant human erythropoietin on nutritional status and plasma lipids in uremic patients. Nephron 1992; 60: 249.

Kokot F. , Wiecek A. , Grzeszczak W. , Klepacka J. , Klin M. , Lao M. Influence of erythropoietin treatment on endocrine abnormalities in hemodialyzed patients. Contrib Nephrol 1989; 76: 257–72.

Navino C. , Barbè M.C. , Zamboni G. , Chiarinotti D. , Cusaro C. , Verzetti G. La migliorata tolleranza glicidica dopo eritropoietina (EPO) negli emodializzati: azione diretta del farmaco o aumento dell'emoglobina? Atti del 32° Congresso Nazionale della Società Italiana di Nefrologia, Bologna 1991. Bologna: Monduzzi 1991; 897–901.

Borissova A.M. , Djambazova A. , Todorov K. , Dakovska L. , Tankova T. , Kirilov G. Effect of erythropoietin on the metabolic state and peripheral insulin sensitivity in diabetic patients on hemodialysis. Nephrol Dial Transplant 1993; 8: 93.

Chagnac A. , Korzets A. , Zevin D. , Levi J. Erythropoietin (EPO) impairs glucose tolerance in hemodialysis patients. Nephrol Dial Transplant 1992; 7: 766–7.

Guarnes V. , Alvarez-Buylla R. Erythrocytes and glucose homeostasis in rats. Diabetes 1989; 38: 410–5.

Dionne K.E. , Colton C.K. , Yarmush M.L. Effect of hypoxia on insulin secretion by isolated rat and canine islets of Langerhans. Diabetes 1993; 42: 12–21.

Allegra V. , Mengozzi G. , D'Achille F. , Canciani D. , Vasile A. Glucose-induced insulin secretion in uremia; role of anemia. Nephron 1992; 62: 246–7.

Allegra V. , Mengozzi G. , Vasile A. Iron deficiency in maintenance hemodialysis patients: assessment of diagnosis criteria and of three different iron treatments. Nephron 1991; 57: 175–82.

Allegra V. , Mengozzi G. , Martimbianco L. , Vasile A. Glucose-induced insulin secretion in uremia: effects of aminophylline infusion and glucose loads. Kidney Int 1990; 38: 1146–50.

Allegra V. , Amendolagine F. , Mengozzi G. , Jesu L. , Vasile A. Metabolic and hormonal assessment of patients on maintenance hemodialysis for 10 years or more and their importance in long-term survival. Nephron 1988; 49: 107–13.

Gotch F.A. , Sargent J.A. A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 1985; 28: 526–34.

Allegra V. , Luisetto G. , Mengozzi G. , Martimbianco L. , Vasile A. Glucose-induced insulin secretion in uremia: role of 1 alpha,25(OH)2-vitamin D3. Nephron 1994; 68: 41–7.

Allegra V. , Mengozzi G. , Martimbianco L. , Vasile A. Glucose-induced insulin secretion in uremia: relation with acid-base balance and effects of bicarbonate administration. Nephron 1993; 63: 43–8.

de Fronzo R.A. , Ferranini E. , Koivisto V. New concepts in the pathogenesis and treatment of non-insulin-dependent diabetes mellitus. Am J Med 1983; 17: 52–81.

Nissenson A.R. Recombinant human erythropoietin: impact on brain and cognitive function, exercise tolerance, sexual potency, and quality of life. Semin Nephrol 1989; 9(Suppl 2): 25–31.

Suwata J. , Maeda H. , Ohmori N. , Ohwa M. , Ohtsuka H. , Shimoyama H. Recombinant human erythropoietin therapy and autonomic nervous system. Nephron 1992; 61: 115–6.

Schaefer R.M. , Kokot F. , Kuerner B. , Zech M. , Heidland A. Normalization of serum prolactin levels in hemodialysis patients on recombinant human erythropoietin. Int J Artif Organs 1989; 12: 445–9.

Cases A. , Escolar G. , Reverter J.C. Recombinant human erythropoietin treatment improves platelet function in uremic patients. Kidney Int 1992; 42: 668–72.

Kimata H. , Yoshida A. , Ishioka C. Human recombinant erythropoietin directly stimulates B cell immunoglobulin production and proliferation in serum-free medium. Clin Exp Immunol 1991; 85: 151–6.

Tsakiris D. , Avramidis M. , Karamitsos K. Cardiopulmunary function in haemodialysis patients before and after treatment of anaemia with erythropoietin. Kidney Int 1991; 39: 196.

Canaud B. , Bouloux C. , Rivory J.P. Erythropoietin-induced changes in protein nutrition: quantitative assessment by urea kinetic modeling analysis. Blood Purif 1990; 8: 301–8.

Barany P. , Pettersson E. , Ahlberg M. Nutritional assessment in anemic hemodialysis patients treated with recombinant human erythropoietin. Clin Nephrol 1991; 35: 270–9.

Toigo G. , Situlin R. , Vasile A. Effects of erythropoietin administration on nutritional state and erythrocyte metabolism in maintenance hemodialysis patients. Contrib Nephrol 1992; 98: 79–88.

Kaupke C.J. , Vaziri N.D. , Sampson J.R. , Atkins K. Effect of erythropoietin therapy on diet and dialysis clearances in hemodialysis patients. Int J Artif Organs 1990; 13: 218–22.